뉴스벤징가
Ionis to Seek Expedited FDA Review for ALS Drug
· 발표
기사 요약
Ionis Pharmaceuticals and Otsuka Pharmaceutical report positive Phase 3 data for ulefnersen, an investigational RNA-targeted drug for ALS.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Ionis Pharmaceuticals and Otsuka Pharmaceutical report positive Phase 3 data for ulefnersen, an investigational RNA-targeted drug for ALS.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…